I interviewed Dr. Sumanta Pal, co-director of the Kidney Cancer Program, City of Hope, about a study he led on the effects of continuing immunotherapy in metastatic kidney cancer patients after it has stopped working.

Episode Sponsored By https://www.carta.healthcare/

Episode Resources

• Connect with Arundhati Parmar
• [email protected]
• https://twitter.com/aparmarbb?lang=en
• https://medcitynews.com/
• Connect with Dr. Sumanta Pal
• https://www.cityofhope.org/sumanta-pal

Review, Subscribe and Share If you like what you hear please leave a review by clicking here

Make sure you're subscribed to the podcast so you get the latest episodes.

• Click here to subscribe with Apple Podcasts
• Click here to subscribe with Spotify
• Click here to subscribe with Podbean
• Click here to subscribe with RSS